The clinical study demonstrated plasma hepcidin as a positive acute-phase reactant in relation to an uncomplicated large cardiac surgery. Hepcidin increase was related to IL-6 concentrations and to duration of surgical procedure.
The clinical findings are in conformity with recent experimental studies defining hepcidin as a type II acute-phase protein.